Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.1834 | 0.5 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.1834 | 0.5 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1834 | 0.5 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.1834 | 0.5 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.1834 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1834 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.1834 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 20.7 uM | Inhibition of Influenza A virus (A/chicken/Sandong/Li/2008(H9N2)) neuraminidase N2 using 4-MU-NANA as substrate after 5 mins by fluorescence assay | ChEMBL. | 23664211 |
IC50 (binding) | = 22.8 uM | Inhibition of Influenza A virus H1N1 A/duck/China/QJ/01 neuraminidase N1 using 4-MU-NANA as substrate after 5 mins by fluorescence assay | ChEMBL. | 23664211 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.